Journal Logo

Core outcome set for pediatric chronic pain clinical trials: results from a Delphi poll and consensus meeting

Palermo, Tonya M.; Walco, Gary A.; Paladhi, Unmesha Roy; More

PAIN. 162(10):2539-2547, October 2021.

Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy

Rice, Andrew S.C.; Dworkin, Robert H.; Finnerup, Nanna B.; More

PAIN. 162(10):2578-2589, October 2021.

Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments

Ma, Jiacheng; Goodwani, Sunil; Acton, Paul J.; More

PAIN. 162(10):2599-2612, October 2021.

Comparative differences in musculoskeletal pain consultation and analgesic prescription for people with dementia: a UK-wide matched cohort study

Bullock, Laurna; Bedson, John; Chen, Ying; More

PAIN. 162(10):2613-2620, October 2021.


Welcome to the 2021 Global Year About Back Pain! This year's theme focuses on helping clinicians, scientists, those living with pain, and the public understand the nature of back pain and the utility of available treatment modalities.

Articles published in PAIN related to this year's theme are marked with the Global Year logo and added to an article collection​.